0 
0 
0 
0.0 
1 minute
Local biotechnology company Absci announced earlier this week that it has laid off about 15 percent of its staff worldwide. The Vancouver-based company made the news public in an SEC filing Tuesday. Thirty employees were laid off Aug. 31 as part of what it termed an organizational realignment. The employees impacted were based both remotely and in Vancouver, according to a statement from the company released Thursday. “This was a difficult decision, and it’s always sad to see talented people who have made significant contributions leave the company,” said Absci founder and CEO Sean McClain.
“However, it’s the right step so that we can strategically invest our efforts in sustaining our (artificial intelligence) competitive edge, and validate our capabilities through the progress of our own pipeline.” The executive went on to add that he sees the company as being at the center of the artificial intelligence transformation in drug creation.
